Stay updated on A(B)VD+Nivolumab in Frontline for HL Clinical Trial
Sign up to get notified when there's something new on the A(B)VD+Nivolumab in Frontline for HL Clinical Trial page.

Latest updates to the A(B)VD+Nivolumab in Frontline for HL Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, indicating a minor page/version update. It does not affect the displayed study information or navigation.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page, signaling a recent system or content update. The study content and primary details remain unchanged.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision: v3.6.4 is now displayed, replacing the previous Revision: v3.6.3, indicating a routine site update rather than a change to the study details.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, reflecting a software/version increment on the page.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2 on the page. This change represents an internal template/version update and does not alter study details or visible content.SummaryDifference0.0%

- Check82 days agoChange DetectedNew sections were added to guide users and inform recruitment status: No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment, along with a new Revision: v3.6.0; the old Intervention / Treatment heading and the older Revision: v3.5.5 label were removed.SummaryDifference0.4%

Stay in the know with updates to A(B)VD+Nivolumab in Frontline for HL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the A(B)VD+Nivolumab in Frontline for HL Clinical Trial page.